IMMUNOVACCINE INC. ("IMV")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: December 5, 2013
TSX Venture Tier 1 Company
TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced on November 15, 2013:
Number of Shares: 10,511,209 common shares
Purchase Price: $0.40 per common share
Number of Placees: 33 placees
Insider / Pro Group Participation:
Name
Insider = Y /
Pro Group = P
Number of
Shares
Albert Scardino
Y
1,250,000
Finders: Simon John Frank Bishop, B & D Capital Partners, Mackie Research Capital, Woodstone Capital Inc., Canaccord Genuity Corp., 3097359 NS Ltd.
Finders' Fees: An aggregate of $82,562 in cash, 167,218 common shares and non-transferable compensation options to purchase 63,000 common shares at a price of $0.40 per share until May 21, 2015.
The Company has confirmed the closing of the above-mentioned Private Placement through a press release dated November 21, 2013.
____________________________________
|
|
